Global Direct-to-consumer Disease Risk and Health Test Market Size, Status and Forecast 2020-2026

The results of these tests estimate your genetic risk of developing several common diseases, such as celiac disease, Parkinson disease, and Alzheimer disease. Some companies also include a person’s carrier status for less common conditions, including cystic fibrosis and sickle cell disease. A carrier is someone who has one copy of a gene mutation that, when present in two copies, causes a genetic disorder.
Market Analysis and Insights: Global Direct-to-consumer Disease Risk and Health Test Market
In 2019, the global Direct-to-consumer Disease Risk and Health Test market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Direct-to-consumer Disease Risk and Health Test Scope and Market Size
Direct-to-consumer Disease Risk and Health Test market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Direct-to-consumer Disease Risk and Health Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Direct-to-consumer Disease Risk and Health Test market is segmented into Celiac Disease, Parkinson Disease, Alzheimer Disease, Other, etc.
Segment by Application, the Direct-to-consumer Disease Risk and Health Test market is segmented into Online, Offline, etc.
Regional and Country-level Analysis
The Direct-to-consumer Disease Risk and Health Test market is analysed and market size information is provided by regions (countries).
The key regions covered in the Direct-to-consumer Disease Risk and Health Test market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Direct-to-consumer Disease Risk and Health Test Market Share Analysis
Direct-to-consumer Disease Risk and Health Test market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Direct-to-consumer Disease Risk and Health Test business, the date to enter into the Direct-to-consumer Disease Risk and Health Test market, Direct-to-consumer Disease Risk and Health Test product introduction, recent developments, etc.
The major vendors include 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes, etc.

This report focuses on the global Direct-to-consumer Disease Risk and Health Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Direct-to-consumer Disease Risk and Health Test development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

23andMe
MyHeritage
LabCorp
Myriad Genetics
Ancestry.com
Quest Diagnostics
Gene By Gene
DNA Diagnostics Center
Invitae
IntelliGenetics
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Xcode
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health
DNA Services of America
Shuwen Health Sciences
Mapmygenome
Full Genomes

Market segment by Type, the product can be split into

Celiac Disease
Parkinson Disease
Alzheimer Disease
Other

Market segment by Application, split into

Online
Offline

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Direct-to-consumer Disease Risk and Health Test status, future forecast, growth opportunity, key market and key players.
To present the Direct-to-consumer Disease Risk and Health Test development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Direct-to-consumer Disease Risk and Health Test are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions